<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37436639</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>25</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2520-8721</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Hormones (Athens, Greece)</Title><ISOAbbreviation>Hormones (Athens)</ISOAbbreviation></Journal><ArticleTitle>Primary adrenal insufficiency due to bilateral adrenal hemorrhage-adrenal infarction in a patient with systemic lupus erythematosus and antiphospholipid syndrome: case presentation and review of the literature.</ArticleTitle><Pagination><StartPage>521</StartPage><EndPage>531</EndPage><MedlinePgn>521-531</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s42000-023-00463-5</ELocationID><Abstract><AbstractText>Primary adrenal insufficiency (PAI) is a rare disease which represents the end stage of a destructive process involving the adrenal cortex. Occasionally it may be caused by bilateral adrenal hemorrhagic infarction in patients with antiphospholipid syndrome (APS). We herein report the challenging case of a 30-year-old female patient with systemic lupus erythematosus (SLE) and secondary APS who was admitted to the emergency department (ED) due to fever, lethargy, and syncopal episodes. Hyponatremia, hyperkalemia, hyperpigmentation, shock, altered mental status, and clinical response to glucocorticoid administration were features highly suggestive of an acute adrenal crisis. The patient's clinical status required admission to the intensive care unit (ICU), where steroid replacement, anticoagulation, and supportive therapy were provided, with a good outcome. Imaging demonstrated bilateral adrenal enlargement attributed to recent adrenal hemorrhage. This case highlights the fact that bilateral adrenal vein thrombosis and subsequent hemorrhage can be part of the thromboembolic complications seen in both primary and secondary APS and which, if misdiagnosed, may lead to a life-threatening adrenal crisis. High clinical suspicion is required for its prompt diagnosis and management. A literature search of past clinical cases with adrenal insufficiency (AI) in the setting of APS and SLE was conducted using major electronic databases. Our aim was to retrieve information about the pathophysiology, diagnosis, and management of similar conditions.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bouki</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Endocrinology and Diabetes Clinic, University Hospital of Heraklion, University of Crete School of Medicine, Voutes, 71500, Heraklion Crete, Crete, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Venetsanaki</LastName><ForeName>V</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Endocrinology and Diabetes Clinic, University Hospital of Heraklion, University of Crete School of Medicine, Voutes, 71500, Heraklion Crete, Crete, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chrysoulaki</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Endocrinology and Diabetes Clinic, University Hospital of Heraklion, University of Crete School of Medicine, Voutes, 71500, Heraklion Crete, Crete, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pateromichelaki</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Rheumatology and Clinical Immunology, University General Hospital of Heraklion, Crete, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Betsi</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Endocrinology and Diabetes Clinic, University Hospital of Heraklion, University of Crete School of Medicine, Voutes, 71500, Heraklion Crete, Crete, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daraki</LastName><ForeName>V</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Endocrinology and Diabetes Clinic, University Hospital of Heraklion, University of Crete School of Medicine, Voutes, 71500, Heraklion Crete, Crete, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sbyrakis</LastName><ForeName>N</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Emergency Department, University General Hospital of Heraklion, Crete, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spanakis</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Interventional Radiology Unit, Department of Medical Imaging, University General Hospital of Heraklion, Crete, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bertsias</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Rheumatology and Clinical Immunology, University General Hospital of Heraklion, Crete, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sidiropoulos</LastName><ForeName>P I</ForeName><Initials>PI</Initials><AffiliationInfo><Affiliation>Rheumatology and Clinical Immunology, University General Hospital of Heraklion, Crete, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xekouki</LastName><ForeName>Paraskevi</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-5205-747X</Identifier><AffiliationInfo><Affiliation>Endocrinology and Diabetes Clinic, University Hospital of Heraklion, University of Crete School of Medicine, Voutes, 71500, Heraklion Crete, Crete, Greece. pxekouki@uoc.gr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Hormones (Athens)</MedlineTA><NlmUniqueID>101142469</NlmUniqueID><ISSNLinking>1109-3099</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016736" MajorTopicYN="Y">Antiphospholipid Syndrome</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000224" MajorTopicYN="Y">Addison Disease</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000307" MajorTopicYN="Y">Adrenal Gland Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000309" MajorTopicYN="Y">Adrenal Insufficiency</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006470" MajorTopicYN="N">Hemorrhage</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007238" MajorTopicYN="N">Infarction</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Addison&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">Adrenal failure</Keyword><Keyword MajorTopicYN="N">Adrenal hemorrhage</Keyword><Keyword MajorTopicYN="N">Adrenal insufficiency</Keyword><Keyword MajorTopicYN="N">Antiphospholipid syndrome</Keyword><Keyword MajorTopicYN="N">Hypoadrenalism</Keyword><Keyword MajorTopicYN="N">Systemic lupus erythematosus</Keyword></KeywordList><CoiStatement>The authors have no competing interests to declare that are relevant to the content of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>25</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>12</Day><Hour>13</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>12</Day><Hour>11</Hour><Minute>12</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37436639</ArticleId><ArticleId IdType="pmc">PMC10449959</ArticleId><ArticleId IdType="doi">10.1007/s42000-023-00463-5</ArticleId><ArticleId IdType="pii">10.1007/s42000-023-00463-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Arlt W, Allolio B. Adrenal insufficiency. Lancet. 2003;361:1881&#x2013;1893. doi: 10.1016/S0140-6736(03)13492-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(03)13492-7</ArticleId><ArticleId IdType="pubmed">12788587</ArticleId></ArticleIdList></Reference><Reference><Citation>Carroll TB, Aron DC, Findling JW, Tyrrell JB (2018) Glucocorticoids and adrenal androgens. In: Gardner DG, Shoback D (eds) Greenspan&#x2019;s basic and clinical endocrinology. Mc Graw Hill, 317&#x2013;326.</Citation></Reference><Reference><Citation>Addison T. On the constitutional and local effects of disease of the supra-renal capsules. London: Samuel Highley; 1855.</Citation></Reference><Reference><Citation>Kendall EC. Hormones of the adrenal cortex in health and disease. Proc Am Philos Soc. 1953;97:8&#x2013;11.</Citation></Reference><Reference><Citation>Sarett LH. Partial synthesis of pregnene-4-triol-17(&#x3b2;), 20(&#x3b2;), 21-dione-3,11 and pregnene-4-diol-17(&#x3b2;), 21-trione-3,11,20 monoacetate. J Biol Chem. 1946;162:601&#x2013;631. doi: 10.1016/S0021-9258(17)41405-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(17)41405-0</ArticleId><ArticleId IdType="pubmed">21018769</ArticleId></ArticleIdList></Reference><Reference><Citation>Reichstein T. The most important hormones of adrenal cortex. Acta Endocrinol (Copenh) 1954;17:375&#x2013;384.</Citation><ArticleIdList><ArticleId IdType="pubmed">13227849</ArticleId></ArticleIdList></Reference><Reference><Citation>Bornstein SR, Allolio B, Arlt W, et al. Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101(2):364&#x2013;389. doi: 10.1210/jc.2015-1710.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2015-1710</ArticleId><ArticleId IdType="pmc">PMC4880116</ArticleId><ArticleId IdType="pubmed">26760044</ArticleId></ArticleIdList></Reference><Reference><Citation>Olafsson AS, Sigurjonsdottir HA. Increasing prevalence of Addison disease: results from a nationwide study. Endocr Pract. 2016;22:30&#x2013;35. doi: 10.4158/EP15754.OR.</Citation><ArticleIdList><ArticleId IdType="doi">10.4158/EP15754.OR</ArticleId><ArticleId IdType="pubmed">26437215</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf8;v&#xe5;s K, Husebye ES. High prevalence and increasing incidence of Addison&#x2019;s disease in western Norway. Clin Endocrinol (Oxf) 2002;56:787&#x2013;791. doi: 10.1046/j.1365-2265.2002.t01-1-01552.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2265.2002.t01-1-01552.x</ArticleId><ArticleId IdType="pubmed">12072049</ArticleId></ArticleIdList></Reference><Reference><Citation>Erichsen MM, L&#xf8;v&#xe5;s K, Skinningsrud B, et al. Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry. J Clin Endocrinol Metab. 2009;94:4882&#x2013;4890. doi: 10.1210/jc.2009-1368.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2009-1368</ArticleId><ArticleId IdType="pubmed">19858318</ArticleId></ArticleIdList></Reference><Reference><Citation>Eaton WW, Rose NR, Kalaydjian A, et al. Epidemiology of autoimmune diseases in Denmark. J Autoimmun. 2007;29:1&#x2013;9. doi: 10.1016/j.jaut.2007.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2007.05.002</ArticleId><ArticleId IdType="pmc">PMC2717015</ArticleId><ArticleId IdType="pubmed">17582741</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer G, Neumann K, Badenhoop K, et al. Increasing prevalence of Addison's disease in German females: health insurance data 2008&#x2013;2012. Eur J Endocrinol. 2014;170(3):367&#x2013;373. doi: 10.1530/EJE-13-0756.</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/EJE-13-0756</ArticleId><ArticleId IdType="pubmed">24322183</ArticleId></ArticleIdList></Reference><Reference><Citation>Laureti S, Vecchi L, Santeusanio F, Falorni A. Is the prevalence of Addison&#x2019;s disease underestimated? J Clin Endocrinol Metab. 1999;84:1762. doi: 10.1210/jcem.84.5.5677-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jcem.84.5.5677-7</ArticleId><ArticleId IdType="pubmed">10323417</ArticleId></ArticleIdList></Reference><Reference><Citation>Willis AC, Vince FP. The prevalence of Addison&#x2019;s disease in Coventry, UK. Postgrad Med J. 1997;73:286&#x2013;288. doi: 10.1136/pgmj.73.859.286.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/pgmj.73.859.286</ArticleId><ArticleId IdType="pmc">PMC2431301</ArticleId><ArticleId IdType="pubmed">9196701</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong MF, Jeffcoate W. Eighty-six cases of Addison&#x2019;s disease. Clin Endocrinol (Oxf) 1994;41:757&#x2013;761. doi: 10.1111/j.1365-2265.1994.tb02790.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2265.1994.tb02790.x</ArticleId><ArticleId IdType="pubmed">7889611</ArticleId></ArticleIdList></Reference><Reference><Citation>Charmandari E, Nicolaides NC, Chrousos GP. Adrenal insufficiency. Lancet. 2014;383(9935):2152&#x2013;67. doi: 10.1016/S0140-6736(13)61684-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(13)61684-0</ArticleId><ArticleId IdType="pubmed">24503135</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry R, Kecha O, Paquette J, et al. Primary adrenal insufficiency in children: twenty years&#x2019; experience at the Sainte-Justine Hospital, Montreal. J Clin Endocrinol Metab. 2005;90:3243&#x2013;3250. doi: 10.1210/jc.2004-0016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2004-0016</ArticleId><ArticleId IdType="pubmed">15811934</ArticleId></ArticleIdList></Reference><Reference><Citation>Carroll TB, Aron DC, Findling JW, Tyrrell JB (2018) Endocrine Emergencies. In: Gardner DG, Shoback D (eds) Greenspan&#x2019;s basic and clinical endocrinology. Mc Graw Hill, pp 788&#x2013;789</Citation></Reference><Reference><Citation>Bansal R, et al. Adrenal insufficiency secondary to bilateral adrenal hemorrhage associated with antiphospholipid syndrome. AACE Clin Case Rep. 2019;6(2):e65&#x2013;e69. doi: 10.4158/ACCR-2019-0376.</Citation><ArticleIdList><ArticleId IdType="doi">10.4158/ACCR-2019-0376</ArticleId><ArticleId IdType="pmc">PMC7282157</ArticleId><ArticleId IdType="pubmed">32524013</ArticleId></ArticleIdList></Reference><Reference><Citation>Presotto F, Fornasini F, Betterle C, et al. Acute adrenal failure as the heralding symptom of primary antiphospholipid syndrome: report of a case and review of the literature. Eur J Endocrinol. 2005;153(4):507&#x2013;514. doi: 10.1530/eje.1.02002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/eje.1.02002</ArticleId><ArticleId IdType="pubmed">16189171</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervera R, Piette JC, Font J, et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum. 2002;46:1019&#x2013;1027. doi: 10.1002/art.10187.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.10187</ArticleId><ArticleId IdType="pubmed">11953980</ArticleId></ArticleIdList></Reference><Reference><Citation>Asherson RA, Cervera R, Piette JC, et al. Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients. Medicine (Baltimore) 1998;77:195&#x2013;207. doi: 10.1097/00005792-199805000-00005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005792-199805000-00005</ArticleId><ArticleId IdType="pubmed">9653431</ArticleId></ArticleIdList></Reference><Reference><Citation>Asherson RA, Cervera R, Piette JC, et al. Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients. Medicine (Baltimore) 2001;80:355&#x2013;377. doi: 10.1097/00005792-200111000-00002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005792-200111000-00002</ArticleId><ArticleId IdType="pubmed">11704713</ArticleId></ArticleIdList></Reference><Reference><Citation>Uthman I, Salti I, Khamashta M. Endocrinologic manifestations of the antiphospholipid syndrome. Lupus. 2006;15(8):485&#x2013;489. doi: 10.1191/0961203306lu2318rr.</Citation><ArticleIdList><ArticleId IdType="doi">10.1191/0961203306lu2318rr</ArticleId><ArticleId IdType="pubmed">16941999</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee KH, Lee H, Lee CH, et al. Adrenal insufficiency in systematic lupus erythematosus (SLE) and antiphospholipid syndrome (APS): A systematic review. Autoimmun Rev. 2019;18(1):1&#x2013;8. doi: 10.1016/j.autrev.2018.06.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2018.06.014</ArticleId><ArticleId IdType="pubmed">30408580</ArticleId></ArticleIdList></Reference><Reference><Citation>Fox B. Venous infarction of the adrenal glands. J Pathol. 1976;119:65&#x2013;89. doi: 10.1002/path.1711190202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.1711190202</ArticleId><ArticleId IdType="pubmed">932879</ArticleId></ArticleIdList></Reference><Reference><Citation>Nieman L. Clinical manifestations of adrenal insufficiency in adults. UpToDate 2023 En: https://www.uptodate.com/contents/clinical-manifestations-of-adrenal-insufficiency-in-adults</Citation></Reference><Reference><Citation>Farah Jde L, Lauand CV, Chequi L, et al. Severe psychotic disorder as the main manifestation of adrenal insufficiency. Case Rep Psychiatry. 2015;2015:512430. doi: 10.1155/2015/512430.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/512430</ArticleId><ArticleId IdType="pmc">PMC4410748</ArticleId><ArticleId IdType="pubmed">25954562</ArticleId></ArticleIdList></Reference><Reference><Citation>Betterle C, Dal Pra C, Mantero F, Zanchetta R. Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocr Rev. 2002;23:327&#x2013;364. doi: 10.1210/edrv.23.3.0466.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/edrv.23.3.0466</ArticleId><ArticleId IdType="pubmed">12050123</ArticleId></ArticleIdList></Reference><Reference><Citation>Hahner S, Ross RJ, Arlt W, et al. Adrenal insufficiency. Nat Rev Dis Primers. 2021;7(1):19. doi: 10.1038/s41572-021-00252-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41572-021-00252-7</ArticleId><ArticleId IdType="pubmed">33707469</ArticleId></ArticleIdList></Reference><Reference><Citation>Arlt W. The approach to the adult with newly diagnosed adrenal insufficiency. J Clin Endocrinol Metab. 2009;94:1059&#x2013;1067. doi: 10.1210/jc.2009-0032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2009-0032</ArticleId><ArticleId IdType="pubmed">19349469</ArticleId></ArticleIdList></Reference><Reference><Citation>Hahner S, Loeffler M, Fassnacht M, et al. Impaired subjective health status in 256 patients with adrenal insufficiency on standard therapy based on cross-sectional analysis. J Clin Endocrinol Metab. 2007;92:3912e22. doi: 10.1038/s41572-021-00252-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41572-021-00252-7</ArticleId><ArticleId IdType="pubmed">17684047</ArticleId></ArticleIdList></Reference><Reference><Citation>Johannsson G, Nilsson AG, Bergthorsdottir R, et al. Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation. J Clin Endocrinol Metab. 2012;97(2):473&#x2013;481. doi: 10.1210/jc.2011-1926.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2011-1926</ArticleId><ArticleId IdType="pubmed">22112807</ArticleId></ArticleIdList></Reference><Reference><Citation>Newell-Price J, Whiteman M, Rostami-Hodjegan A, et al. Modified-release hydrocortisone for circadian therapy: a proof-of principle study in dexamethasone-suppressed normal volunteers. Clin Endocrinol (Oxf) 2008;68:130&#x2013;135. doi: 10.1111/j.1365-2265.2007.03011.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2265.2007.03011.x</ArticleId><ArticleId IdType="pubmed">17803699</ArticleId></ArticleIdList></Reference><Reference><Citation>Debono M, Ghobadi C, Rostami-Hodjegan A, et al. Modified-release hydrocortisone to provide circadian cortisol profiles. J Clin Endocrinol Metab. 2009;94:1548&#x2013;1554. doi: 10.1210/jc.2008-2380.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2008-2380</ArticleId><ArticleId IdType="pmc">PMC2684472</ArticleId><ArticleId IdType="pubmed">19223520</ArticleId></ArticleIdList></Reference><Reference><Citation>Husebye ES, Pearce SH, Krone NP, K&#xe4;mpe O. Adrenal insufficiency. Lancet. 2021;397(10274):613&#x2013;629. doi: 10.1016/S0140-6736(21)00136-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)00136-7</ArticleId><ArticleId IdType="pubmed">33484633</ArticleId></ArticleIdList></Reference><Reference><Citation>Munir S, Quintanilla Rodriguez BS, Waseem M (2022) Addison disease. 15. In: StatPearls. StatPearls Publishing, Treasure Island (FL)</Citation><ArticleIdList><ArticleId IdType="pubmed">28723023</ArticleId></ArticleIdList></Reference><Reference><Citation>Godswill OC, Odigie OO. Primary adrenal insufficiency (Addison's disease) associated with systemic lupus erythematosus: a rare occurrence. Int J Prev Med. 2014;5(10):1324&#x2013;1327.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4223953</ArticleId><ArticleId IdType="pubmed">25400892</ArticleId></ArticleIdList></Reference><Reference><Citation>Eichner HL, Schambelan M, Biglieri EG. Systemic lupus erythematosus with adrenal insufficiency. Am J Med. 1973;55:700&#x2013;705. doi: 10.1016/0002-9343(73)90194-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9343(73)90194-0</ArticleId><ArticleId IdType="pubmed">4356101</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrada AA, Escobedo N, Iruretagoyena M, et al. Innate immune cells' contribution to systemic lupus Erythematosus. Front Immunol. 2019;15(10):772. doi: 10.3389/fimmu.2019.00772.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.00772</ArticleId><ArticleId IdType="pmc">PMC6476281</ArticleId><ArticleId IdType="pubmed">31037070</ArticleId></ArticleIdList></Reference><Reference><Citation>Aringer M, Costenbader K, Daikh D, et al. 2019 European league against rheumatism/American college of rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis. 2019;78(9):1151&#x2013;1159. doi: 10.1136/annrheumdis-2018-214819.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2018-214819</ArticleId><ArticleId IdType="pubmed">31383717</ArticleId></ArticleIdList></Reference><Reference><Citation>Asherson RA, Cervera R, de Groot PG, et al. Catastrophic Antiphospholipid Syndrome Registry Project Group. Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus. 2003;12(7):530&#x2013;4. doi: 10.1191/0961203303lu394oa.</Citation><ArticleIdList><ArticleId IdType="doi">10.1191/0961203303lu394oa</ArticleId><ArticleId IdType="pubmed">12892393</ArticleId></ArticleIdList></Reference><Reference><Citation>Tektonidou MG, Andreoli L, Limper M, et al. EULAR recommendations for the management of antiphospholipid syndrome in adults. Ann Rheum Dis. 2019;78:1296&#x2013;1304. doi: 10.1136/annrheumdis-2019-215213.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2019-215213</ArticleId><ArticleId IdType="pubmed">31092409</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) J Thromb Haemost. 2006;4:295&#x2013;306. doi: 10.1111/j.1538-7836.2006.01753.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2006.01753.x</ArticleId><ArticleId IdType="pubmed">16420554</ArticleId></ArticleIdList></Reference><Reference><Citation>Chayoua W, Kelchtermans H, Moore GW, et al. Identification of high thrombotic risk triple-positive antiphospholipid syndrome patients is dependent on anti-cardiolipin and anti-&#x3b2;2glycoprotein I antibody detection assays. J Thromb Haemost. 2018;16(10):2016&#x2013;2023. doi: 10.1111/jth.14261.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14261</ArticleId><ArticleId IdType="pubmed">30079628</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehdi AA, Salti I, Uthman I. Antiphospholipid syndrome: endocrinologic manifestations and organ involvement. Semin Thromb Hemost. 2011;37:49&#x2013;57. doi: 10.1055/s-0030-1270071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0030-1270071</ArticleId><ArticleId IdType="pubmed">21305801</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliveira D, et al. Addison's disease in antiphospholipid syndrome: a rare complication. Endocrinol Diabetes Metab Case Rep. 2018;2018:18&#x2013;0118. doi: 10.1530/EDM-18-0118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/EDM-18-0118</ArticleId><ArticleId IdType="pmc">PMC6280132</ArticleId><ArticleId IdType="pubmed">30481151</ArticleId></ArticleIdList></Reference><Reference><Citation>Kozamernik M, et al. Adrenal failure and antiphospholipid syndrome. J Int Med Res. 2020;48(7):300060520903659. doi: 10.1177/0300060520903659.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0300060520903659</ArticleId><ArticleId IdType="pmc">PMC7375731</ArticleId><ArticleId IdType="pubmed">32692293</ArticleId></ArticleIdList></Reference><Reference><Citation>Espinosa G, Santos E, Cervera R, et al. Adrenal involvement in the antiphospholipid syndrome: clinical and immunologic characteristics of 86 patients. Medicine (Baltimore) 2003;82(2):106&#x2013;118. doi: 10.1097/00005792-200303000-00005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005792-200303000-00005</ArticleId><ArticleId IdType="pubmed">12640187</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramon I, Mathian A, Bachelot A, et al. Primary adrenal insufficiency due to bilateral adrenal hemorrhage-adrenal infarction in the antiphospholipid syndrome: long-term outcome of 16 patients. J Clin Endocrinol Metab. 2013;98(8):3179&#x2013;3189. doi: 10.1210/jc.2012-4300.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2012-4300</ArticleId><ArticleId IdType="pubmed">23783099</ArticleId></ArticleIdList></Reference><Reference><Citation>Anson BJ, Cauldwell EW. The blood supply of the kidney, suprarenal gland, and associated structures. Surg Gynecol Obstet. 1947;84:313&#x2013;320.</Citation><ArticleIdList><ArticleId IdType="pubmed">20284768</ArticleId></ArticleIdList></Reference><Reference><Citation>Berneis K, Buitrago-T&#xe9;llez C, Muller B, et al. Case Report. Antiphospholipid syndrome and endocrine damage: why bilateral adrenal thrombosis? Eur J Haematol. 2003;71:299&#x2013;302. doi: 10.1034/j.1600-0609.2003.00145.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1034/j.1600-0609.2003.00145.x</ArticleId><ArticleId IdType="pubmed">12950241</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu XY, Zhang L, Yang XX, Zhu TN. Primary adrenal insufficiency due to bilateral adrenal hematomas in a patient with primary antiphospholipid syndrome. Chin Med J (Engl) 2017;130(20):2517&#x2013;2518. doi: 10.4103/0366-6999.216410.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0366-6999.216410</ArticleId><ArticleId IdType="pmc">PMC5684628</ArticleId><ArticleId IdType="pubmed">29052579</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolinioti A, Tsimaras M, Stravodimos G, Komporozos V. Acute adrenal insufficiency due to adrenal hemorrhage complicating colorectal surgery: report of two cases and correlation with the antiphospholipid antibody syndrome. Int J Surg Case Rep. 2018;51:90&#x2013;94. doi: 10.1016/j.ijscr.2018.07.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijscr.2018.07.034</ArticleId><ArticleId IdType="pmc">PMC6111066</ArticleId><ArticleId IdType="pubmed">30145500</ArticleId></ArticleIdList></Reference><Reference><Citation>You JY, Fleischer N, Abraham SB. Evolving adrenal disfunction after bilateral adrenal infarction: a case report. AACE Clin Case Rep. 2019;5(6):e334&#x2013;e339. doi: 10.4158/ACCR-2019-0167.</Citation><ArticleIdList><ArticleId IdType="doi">10.4158/ACCR-2019-0167</ArticleId><ArticleId IdType="pmc">PMC6873843</ArticleId><ArticleId IdType="pubmed">31967065</ArticleId></ArticleIdList></Reference><Reference><Citation>Warriach SA, Mustafa M, O'Keeffe D, Watts M. Unusual case of antiphospholipid syndrome presenting as adrenal insufficiency. BMJ Case Rep. 2020;13(3):e233631. doi: 10.1136/bcr-2019-233631.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2019-233631</ArticleId><ArticleId IdType="pmc">PMC7078771</ArticleId><ArticleId IdType="pubmed">32188612</ArticleId></ArticleIdList></Reference><Reference><Citation>Medina G, Jim&#xe9;nez-Arellano MP, Mu&#xf1;oz-Sol&#xed;s A, Serv&#xed;n-Torres E, Ram&#xed;rez-Mendoza P, Jara LJ. Primary antiphospholipid syndrome, Addison disease, and adrenal incidentaloma. Clin Rheumatol. 2020;39(6):1997&#x2013;2001. doi: 10.1007/s10067-020-04978-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-020-04978-9</ArticleId><ArticleId IdType="pubmed">32146613</ArticleId></ArticleIdList></Reference><Reference><Citation>Arosemena MA, Rodriguez A, Ediriweera H. Bilateral adrenal haemorrhage secondary to rivaroxaban in a patient with antiphospholipid syndrome. BMJ Case Rep. 2020;13(7):e234947. doi: 10.1136/bcr-2020-234947.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2020-234947</ArticleId><ArticleId IdType="pmc">PMC7332187</ArticleId><ArticleId IdType="pubmed">32611655</ArticleId></ArticleIdList></Reference><Reference><Citation>Yazdi F, Shakibi MR, Mirkamali H, Baniasad A. Addison's disease in antiphospholipid syndrome: A rare complication. Clin Case Rep. 2021;9(5):e04107. doi: 10.1002/ccr3.4107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ccr3.4107</ArticleId><ArticleId IdType="pmc">PMC8133072</ArticleId><ArticleId IdType="pubmed">34026149</ArticleId></ArticleIdList></Reference><Reference><Citation>Billet AC, Chevallier O, Samson M, Petit JM, Bonnotte B, Audia S. Adrenal insufficiency revealing a bilateral adrenal hemorrhage-adrenal infarction related to antiphospholipid syndrome. Am J Med. 2022;135(2):194&#x2013;195. doi: 10.1016/j.amjmed.2021.08.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2021.08.011</ArticleId><ArticleId IdType="pubmed">34509446</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan JW, Shukla A, Hu JR, Majumdar SK. Spontaneous adrenal hemorrhage with mild hypoadrenalism in a patient anticoagulated with apixaban for antiphospholipid syndrome: a case report and literature review. Case Rep Endocrinol. 2022;30(2022):6538800.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9729038</ArticleId><ArticleId IdType="pubmed">36504598</ArticleId></ArticleIdList></Reference><Reference><Citation>Allolio B. Extensive expertise in endocrinology. Adrenal crisis. Eur J Endocrinol. 2015;172(3):R115&#x2013;R124. doi: 10.1530/EJE-14-0824.</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/EJE-14-0824</ArticleId><ArticleId IdType="pubmed">25288693</ArticleId></ArticleIdList></Reference><Reference><Citation>Rushworth RL, Torpy DJ, Falhammar H. Adrenal crisis. N Engl J Med. 2019;381(9):852&#x2013;861. doi: 10.1056/NEJMra1807486.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1807486</ArticleId><ArticleId IdType="pubmed">31461595</ArticleId></ArticleIdList></Reference><Reference><Citation>Vella A, Nippoldt TD, et al. Adrenal haemorrhage: a 25- year experience at the Mayo clinic. Mayo Clin Proc. 2001;76:161&#x2013;168. doi: 10.1016/S0025-6196(11)63123-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0025-6196(11)63123-6</ArticleId><ArticleId IdType="pubmed">11213304</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>